基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the complete record of transactions filed by Torti Frank, 董事. Officer active across 2 companies, notably Immunovant, Inc.. In total, 11 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €118k. Activity tracked since 10 January 2022. The latest transaction was disclosed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Torti Frank is Administrateur at Immunovant, Inc. and President and Vant Chair at Roivant Sciences Ltd. He has 11 filings in total, and across the 11 sampled filings, buys total 118215 EUR, sells total 0 EUR, with filings dated from 2022-01-12 to 2026-04-09. The most common transaction nature is Attribution.